Advances in the treatment of central serous chorioretinopathy

Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to...

Full description

Saved in:
Bibliographic Details
Published inSaudi journal of ophthalmology Vol. 29; no. 4; pp. 278 - 286
Main Author Abouammoh, Marwan A.
Format Journal Article
LanguageEnglish
Published Saudi Arabia Elsevier B.V 01.10.2015
Elsevier
Subjects
Central serous chorioretinopathy
Central serous retinopathy
Corticosteroids
CSCR
Photodynamic therapy
Review
Treatment
CSCR
Central serous retinopathy
Photodynamic therapy
Corticosteroids
Treatment
Central serous chorioretinopathy
Online AccessGet full text

Cover

Abstract Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to various treatment models. Enhanced depth imaging optical coherence tomography, in particular, has helped in observing choroidal thickness changes after various treatment models. To date, photodynamic therapy and focal laser remain the main stay of treatment. More understanding of disease pathophysiology in the future will help in determining the drug of choice and the best management option for such cases.
AbstractList Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to various treatment models. Enhanced depth imaging optical coherence tomography, in particular, has helped in observing choroidal thickness changes after various treatment models. To date, photodynamic therapy and focal laser remain the main stay of treatment. More understanding of disease pathophysiology in the future will help in determining the drug of choice and the best management option for such cases.
Author Abouammoh, Marwan A.
AuthorAffiliation King Saud University, Riyadh, Saudi Arabia
AuthorAffiliation_xml – name: King Saud University, Riyadh, Saudi Arabia
Author_xml – sequence: 1
  givenname: Marwan A.
  surname: Abouammoh
  fullname: Abouammoh, Marwan A.
  email: dr.abouammoh@gmail.com
  organization: King Saud University, Riyadh, Saudi Arabia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26586979$$D View this record in MEDLINE/PubMed
BookMark eNp9kE1PAjEQhnvQiKC_wMTs0Qtru9st7UETQvxKTLzouRnaWSmBLbaFhH9vETR68TSHeeadmadPjjrfISEXjJaMMnE9L-Pcr1JZUdaUlJWUjo7IKauZGvKm5j3Sj3FOqZC1rE9IrxKNFGqkTsnN2G6gMxgL1xVphkUKCGmJXSp8W5hcAyyKiMGvY2FmPjgfMLnOryDNtmfkuIVFxPNDHZC3-7vXyePw-eXhaTJ-HhreqDSUFYdWMq4UE1LJtqFQAU5b4MLUHBi0KMBaPgUwQlkjM9QAWMWksMKIekBu97mr9XSJ9nCWXgW3hLDVHpz-2-ncTL_7jeaiaiomc8DVISD4jzXGpJcuGlwsoMP8mWYjrkQWWdGM1nvUBB9jwPZnDaN6J1vP9ZdsvZOtKdNZdp66_H3hz8y36Qzc7AHMnjYOg47GYTZvXUCTtPXu3wWfLImX6g
CitedBy_id crossref_primary_10_1007_s00417_018_4109_3
crossref_primary_10_15406_aovs_2017_06_00196
crossref_primary_10_1016_j_oftal_2016_02_007
crossref_primary_10_1038_s41598_023_28890_9
crossref_primary_10_4103_2211_5056_362040
crossref_primary_10_3390_medicina60010122
crossref_primary_10_17116_oftalma202313906141
crossref_primary_10_1186_s40662_023_00349_y
crossref_primary_10_1007_s10792_023_02691_5
crossref_primary_10_17116_oftalma2019135052293
crossref_primary_10_4103_erj_erj_9_20
crossref_primary_10_1186_s40942_023_00443_2
crossref_primary_10_1097_IAE_0000000000001917
crossref_primary_10_1016_j_oftale_2016_05_005
crossref_primary_10_1080_08820538_2016_1228985
crossref_primary_10_1080_17434440_2016_1236678
crossref_primary_10_1007_s10278_021_00459_w
crossref_primary_10_7759_cureus_46100
crossref_primary_10_1109_ACCESS_2021_3108395
Cites_doi 10.1016/j.ophtha.2013.09.024
10.1136/bjo.63.10.674
10.1172/JCI61427
10.1097/IAE.0b013e31825dd281
10.1016/S0161-6420(96)30386-2
10.1016/S0161-6420(02)01157-0
10.1016/j.mehy.2009.03.036
10.1016/j.oftal.2011.06.012
10.1016/S0161-6420(84)34117-3
10.1016/j.ajo.2014.01.022
10.1097/00006982-199616030-00004
10.1097/IAE.0b013e31821c3ef6
10.1155/2014/631687
10.1159/000324599
10.1136/bjo.2010.181149
10.1034/j.1600-0420.2001.079004417.x
10.1089/jop.2011.0045
10.1007/BF02169203
10.1097/IAE.0b013e318297a07a
10.1016/j.ophtha.2008.04.014
10.1097/IAE.0b013e3181f04a35
10.1136/bjo.79.10.922
10.1007/s00417-009-1104-8
10.2147/OPTH.S39584
10.1038/sj.eye.6702449
10.1007/BF02150023
10.1038/eye.2013.24
10.1002/lsm.20720
10.1136/bjophthalmol-2011-300183
10.1016/j.ajo.2011.08.015
10.1097/ICB.0000000000000007
10.1097/IAE.0b013e318156db8a
10.1001/archopht.1984.01040031049021
10.1097/IAE.0b013e3181fbce8e
10.1097/00006982-199911000-00005
10.1097/IAE.0b013e3181a6c028
10.1007/s10384-012-0162-3
10.1007/s00417-010-1581-9
10.1016/j.ophtha.2008.08.026
10.1136/bjo.68.5.329
10.1136/bjo.2006.090282
10.1007/s10384-008-0613-z
10.1007/s00417-011-1651-7
10.1055/s-2008-1045583
10.1016/S0161-6420(02)01303-9
10.1007/s00417-008-0856-x
10.3109/15569527.2013.810633
10.1097/IAE.0b013e3181cdf381
10.1159/000224782
10.1016/0002-9394(73)90887-8
10.1007/s00417-011-1900-9
10.1016/j.ajo.2009.08.026
10.2147/TCRM.S50407
10.1007/s00417-005-0175-4
10.1016/S0008-4182(05)80040-7
10.1038/eye.2012.66
10.1177/112067210901900415
10.1111/j.1442-9071.2009.02157.x
10.1177/112067210801800613
10.3928/15428877-20090430-14
10.1136/bjo.87.12.1453
10.1089/jop.2006.22.145
10.5301/EJO.2011.6290
10.1007/BF00164568
10.1136/bjo.77.6.349
10.1111/cxo.12125
10.1097/00006982-198700720-00009
10.1097/00006982-198600620-00003
10.1136/bjo.2010.182121
10.1097/IAE.0b013e31820a6a17
10.1007/s00347-013-3001-0
10.1016/0002-9394(83)90265-9
10.1001/archopht.1974.03900060257001
10.1167/iovs.05-0268
10.1016/S0002-9394(99)00075-6
10.2147/TCRM.S54213
10.1186/1471-2415-4-15
10.1001/archopht.1993.01090090081024
10.1016/j.ajo.2007.02.039
10.1007/BF00195356
10.2147/OPTH.S12583
10.3109/08820538.2013.793728
10.1089/jop.2012.0072
10.1016/S0002-9394(14)70531-8
10.1097/00006982-198700730-00005
10.1097/00006982-200011000-00008
10.1097/IAE.0b013e3181d8e7fe
10.1073/pnas.85.22.8415
10.1111/j.1755-3768.2008.01408.x
10.1016/j.mehy.2004.02.020
10.2147/OPTH.S16014
10.1007/s00417-009-1212-5
10.2147/OPTH.S28239
10.1136/bjo.68.11.815
10.1111/j.1442-9071.2005.01027.x
10.1001/archopht.1984.01040030359038
10.1007/s00417-008-1014-1
10.1016/j.jcjo.2011.12.020
10.1097/IAE.0b013e3181be0a83
10.1097/ICU.0b013e3283459826
10.1016/j.ajo.2009.10.011
10.1136/bjo.72.11.829
10.1111/j.1755-3768.2008.01467.x
10.1111/aos.12392
10.1097/IAE.0b013e3181bcf0b4
10.1097/ICB.0b013e3182235561
10.1038/eye.2012.273
10.1016/j.ajo.2011.04.008
10.1007/s00417-013-2270-2
10.1016/j.ajo.2009.11.017
10.1172/JCI115315
10.1007/s00417-013-2289-4
10.1016/j.ajo.2013.10.013
10.1016/j.ophtha.2010.01.023
10.1097/IAE.0b013e318050ca69
ContentType Journal Article
Copyright 2015
2015 Production and hosting by Elsevier B.V. on behalf of Saudi Ophthalmological Society, King Saud University. 2015
Copyright_xml – notice: 2015
– notice: 2015 Production and hosting by Elsevier B.V. on behalf of Saudi Ophthalmological Society, King Saud University. 2015
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.sjopt.2015.01.007
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 286
ExternalDocumentID 10_1016_j_sjopt_2015_01_007
26586979
S1319453415000235
Genre Journal Article
Review
GroupedDBID ---
--K
0R~
0SF
1B1
4.4
457
53G
5VS
6I.
71M
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AALRI
AAQFI
AAXUO
ABCQX
ABMAC
ACGFS
ADBBV
ADEZE
ADMUD
AEXQZ
AFTJW
AGHFR
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BCNDV
DIK
E3Z
EBS
EJD
EP3
FDB
FEDTE
FNPLU
GROUPED_DOAJ
GX1
HVGLF
HYE
HZ~
IAO
IHR
IPNFZ
IXB
KQ8
L7B
M41
NCXOZ
O-L
O9-
OK1
OVD
OZT
RIG
RMW
ROL
RPM
SEL
SES
SSZ
TEORI
W3E
XH2
~S-
ADVLN
AKRWK
H13
ITC
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c459t-824af8149916898f50a2aebfa46c34a1afe6add4baac69dc88985aad9186d6c63
IEDL.DBID RPM
ISSN 1319-4534
IngestDate Tue Sep 17 21:21:12 EDT 2024
Fri Aug 16 01:37:34 EDT 2024
Thu Sep 26 18:28:14 EDT 2024
Sat Sep 28 08:02:29 EDT 2024
Fri Feb 23 02:26:00 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords CSCR
Central serous retinopathy
Photodynamic therapy
Corticosteroids
Treatment
Central serous chorioretinopathy
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c459t-824af8149916898f50a2aebfa46c34a1afe6add4baac69dc88985aad9186d6c63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625218/
PMID 26586979
PQID 1749601620
PQPubID 23479
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4625218
proquest_miscellaneous_1749601620
crossref_primary_10_1016_j_sjopt_2015_01_007
pubmed_primary_26586979
elsevier_sciencedirect_doi_10_1016_j_sjopt_2015_01_007
PublicationCentury 2000
PublicationDate 2015-10-01
PublicationDateYYYYMMDD 2015-10-01
PublicationDate_xml – month: 10
  year: 2015
  text: 2015-10-01
  day: 01
PublicationDecade 2010
PublicationPlace Saudi Arabia
PublicationPlace_xml – name: Saudi Arabia
PublicationTitle Saudi journal of ophthalmology
PublicationTitleAlternate Saudi J Ophthalmol
PublicationYear 2015
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Tarantola, Law, Recchia, Sternberg, Agarwal (b0335) 2008; 40
Aggio, Roisman, Melo, Lavinsky, Cardillo, Farah (b0195) 2010; 30
Klein, Van Buskirk, Friedman, Gragoudas, Chandra (b0185) 1974; 91
Agarwal (b0080) 2011
Ruiz-Moreno, Lugo, Armadá (b0360) 2010; 88
Slusher (b0250) 1986; 6
Lim, Kim (b0535) 2011; 249
Bae, Heo, Kim (b0500) 2014; 121
Jampol, Weinreb, Yannuzzi (b0160) 2002; 109
Dang, Sun, Xu (b0420) 2014; 10
Kang, Kim (b0465) 2013; 27
Rahbani-Nobar, Javadzadeh, Ghojazadeh, Rafeey, Ghorbanihaghjo (b0645) 2011; 17
Ohkuma, Hayashi, Sakai, Watanabe, Tsuneoka (b0460) 2013; 251
O’Connor (b0105) 1975; 7
Bujarborua, Nagpal, Deka (b0110) 2010; 248
Spaide, Hall, Haas (b0115) 1996; 16
Bujarborua (b0205) 2001; 79
Baran, Gürlü, Esgin (b0200) 2005; 33
Avci, Deutman (b0610) 1993; 202
Bae, Heo, Kim (b0450) 2011; 152
Gass (b0020) 1977; 83
Nicolò, Zoli, Musolino, Traverso (b0435) 2012; 153
Karakus, Basarir, Pinarci, Kirandi, Demirok (b0415) 2013; 27
Türkcü, Yüksel, Sahin (b0070) 2014; 33
Polak, Baarsma, Snyers (b0045) 1995; 79
.
Ravage, Packo, Creticos, Merrill (b0590) 2012; 6
Sahin, Bez, Kaya, Türkcü, Sahin, Yüksel (b0235) 2014; 29
Golshahi, Klingmüller, Holz, Eter (b0555) 2010; 88
Gupta, Elagouz, McHugh, Chong, Sivaprasad (b0290) 2009; 37
Nielsen, Jampol (b0560) 2011; 31
Chan, Lai, Lai, Liu, Lam (b0325) 2008; 115
Lim, Kim, Shin (b0485) 2010; 30
Torres-Soriano, García-Aguirre, Kon-Jara (b0530) 2008; 246
Arevalo, Espinoza (b0510) 2011; 249
Novak, Singerman, Rice (b0255) 1987; 7
Maier, Stumpfe, Feucht, Strobl, Rath, Lohmann (b0570) 2014; 111
Tatham, Macfarlane (b0605) 2006; 22
Okushiba, Takeda (b0130) 1997; 101
(4): 503–5. doi
Montero JA, Ruiz-Moreno JM, Fernandez-Muñoz M.
Schmidt-Erfurth, Laqua, Schlötzer-Schrehard, Viestenz, Naumann (b0330) 2002; 120
Spitznas (b0140) 1986; 224
Maumenee (b0015) 1965; 69
Jung, Kim, Sohn, Yang (b0495) 2014; 97
Sakaue, Hoffman (b0165) 1991; 88
Nicoló, Eandi, Alovisi (b0470) 2014; 157
Giusti, Mauget-Faÿsse (b0635) 2004; 134
Butler, Fung, Merkur, Albiani, Forooghian (b0445) 2012; 47
5th ed. Schachat A, Wilkinson C, Hinton D, Sadda S, Wiedemann P, editors. Saunders; 2012. p. 1291–305.
Bousquet, Beydoun, Zhao, Hassan, Offret, Behar-Cohen (b0565) 2013; 33
Yannuzzi (b0025) 1986; 84
Forooghian, Meleth, Cukras, Chew, Wong, Meyerle (b0600) 2011; 31
Lee, Kim (b0455) 2011; 95
Maruko, Iida, Ojima, Sekiryu (b0090) 2011; 31
Seong, Bae, Kim, Han, Nam, Kim (b0475) 2009; 223
Chan, Lai, Liu, Lam (b0545) 2007; 143
Kim, Oh, Oh, Huh (b0390) 2009; 40
Meyerle, Freund, Bhatnagar, Shah, Yannuzzi (b0550) 2007; 27
Ficker, Vafidis, While, Leaver (b0270) 1988; 72
Ie, Yannuzzi, Spaide, Rabb, Blair, Daily (b0095) 1993; 77
Chan, Lam, Lai, Tam, Liu, Chan (b0340) 2003; 87
Lanzetta, Furlan, Morgante, Veritti, Bandello (b0285) 2008; 18
Dang, Mu, Zhao, Li, Guo, Zhu (b0650) 2013; 9
Inoue, Sawa, Tsujikawa, Gomi (b0345) 2010; 149
Copete, Ruiz-Moreno, Cava, Montero (b0365) 2012; 250
Imamura, Fujiwara, Margolis, Spaide (b0125) 2009; 29
Tittl, Spaide, Wong (b0065) 1999; 128
Ricci, Missiroli, Regine, Grossi, Dorin (b0295) 2009; 247
Mitsui, Matsubara, Kanagawa (b0245) 1969; 20
Hussain, Khanna, Hussain, Das (b0315) 2006; 244
Conrad, Geiser, Kleiman, Zur, Karpawitz-Godt (b0230) 2014; 2014
Pikkel, Beiran, Ophir, Miller (b0620) 2002; 109
Schaal, Hoeh, Scheuerle, Schuett, Dithmar (b0480) 2009; 19
Koskela, Laatikainen, von Dickhoff (b0215) 1994; 232
Yannuzzi, Shakin, Fisher, Altomonte (b0010) 1984; 91
Lim, Roh, Kwon (b0505) 2010; 30
Harada, Harada (b0055) 1985; 60
Alcubierre, Arias, Lorenzo, Pujol, Rubio (b0440) 2012; 87
Leaver, Williams (b0265) 1979; 63
Gilbert, Owens, Smith, Fine (b0030) 1984; 68
Tittl, Maar, Polska, Weigert, Stur, Schmetterer (b0135) 2005; 46
Shukla, Kolluru, Vignesh, Karthikprakash, Kim (b0310) 2008; 22
Gass (b0100) 1973; 75
Maaranen, Tuppurainen, Mäntyjärvi (b0220) 2000; 20
Vasconcelos, Marques, Santos (b0370) 2013; 251
Giudice, de Belvis, Tavolato, Galan (b0320) 2011; 5
Steinle, Gupta, Yuan, Singh (b0585) 2012; 96
Robertson, Ilstrup (b0260) 1983; 95
Kawamura, Ideta, Hori (b0305) 2012; 6
Von Graefe (b0005) 1866; 12
Marmor (b0150) 1988; 226
Aydin (b0515) 2013; 29
Fok, Chan, Lam, Lai (b0275) 2011; 46
Kurup, Oliver, Emanuelli, Hau, Callanan (b0655) 2012; 32
Uetani, Ito, Oiwa, Ishikawa, Terasaki (b0430) 2012; 26
Negi, Marmor (b0145) 1984; 102
Prünte, Flammer (b0040) 1996; 121
Mudvari, Goff, Fu (b0190) 2007; 27
Zhao, Célérier, Bousquet (b0175) 2012; 122
Ratanasukon, Thongthong, Bhurayanontachai, Jirarattanasopa (b0410) 2013; 7
Ross, Ross, Mohamed (b0180) 2011; 22
Lim, Kang, Kim, Chung, Lee (b0395) 2011; 95
Maruko, Iida, Sugano, Ojima, Ogasawara, Spaide (b0405) 2010; 117
Hadcock, Malbon (b0170) 1988; 85
Yannuzzi (b0035) 1987; 7
Wakakura, Ishikawa (b0050) 1984; 68
Ryan S.
Caccavale, Imparato, Romanazzi, Negri, Porta, Ferentini (b0625) 2009; 73
Semeraro, Romano, Danzi, Morescalchi, Costagliola (b0520) 2012; 56
Yannuzzi (b0240) 2010; 149
Bouzas, Scott, Mastorakos, Chrousos, Kaiser-Kupfer (b0060) 1993; 111
Nelson, Saggau, Nielsen (b0595) 2014; 8
Moon, Yu, Kim, Kim, Chung (b0350) 2009; 247
Giusti (b0640) 2004; 63
Shin, Lim (b0490) 2011; 31
Desai, Alhalel, Campen, Schiffman, Edwards, Jacobsen (b0085) 2003; 95
Lee, Kim, Lee (b0375) 2009; 53
Lai, Chan, Li, Lai, Liu, Lam (b0385) 2006; 90
Caccavale, Romanazzi, Imparato, Negri, Morano, Ferentini (b0630) 2010; 4
Zhao, Zhou, Xiao (b0425) 2009; 29
Levy, Marcus, Belfair, Klemperer, Lifshitz (b0225) 2005; 40
Breukink, den Hollander, Keunen, Boon, Hoyng (b0575) 2014
Verma, Sinha, Venkatesh, Tewari (b0300) 2004; 4
Chen, Hwang, Tseng, Lin (b0280) 2008; 115
Tsakonas, Kotsolis, Koutsandrea, Georgalas, Papaconstantinou, Ladas (b0355) 2012; 6
Folk, Thompson, Han, Brown (b0210) 1984; 102
Kim, Lee, Lee (b0400) 2014; 157
Chrapek, Jirkova, Kandrnal, Rehak, Sin (b0615) 2013
Reibaldi, Cardascia, Longo (b0380) 2010; 149
Spaide, Campeas, Haas (b0075) 1996; 103
Iida, Kishi, Hagimura, Shimizu (b0120) 1999; 19
Lee, Adelman (b0525) 2011; 27
Gruszka (b0580) 2013; 17
23109801 - Clin Ophthalmol. 2012;6:1639-44
19456313 - Acta Ophthalmol. 2010 Aug;88(5):576-81
6703994 - Arch Ophthalmol. 1984 Mar;102(3):445-9
24184226 - Am J Ophthalmol. 2014 Feb;157(2):366-373.e1
15516262 - BMC Ophthalmol. 2004 Oct 29;4:15
20172062 - Am J Ophthalmol. 2010 Mar;149(3):361-363
24698599 - Acta Ophthalmol. 2014 Sep;92(6):e488-90
21878843 - Retina. 2011 Oct;31(9):1928-36
12911253 - J Natl Med Assoc. 2003 Jul;95(7):553-9
19629018 - Retina. 2009 Sep;29(8):1155-61
8554078 - Am J Ophthalmol. 1996 Jan;121(1):26-34
24487046 - Am J Ophthalmol. 2014 May;157(5):1033-7
19521133 - Ophthalmologica. 2009;223(5):343-7
16722801 - J Ocul Pharmacol Ther. 2006 Apr;22(2):145-9
3306853 - Retina. 1987 Summer;7(2):111-31
6084221 - Ophthalmology. 1984 Dec;91(12):1554-72
22925113 - J Ocul Pharmacol Ther. 2013 Feb;29(1):10-3
6541945 - Br J Ophthalmol. 1984 Nov;68(11):815-20
888264 - Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 May-Jun;83(3 Pt 1):456-67
22019224 - Am J Ophthalmol. 2012 Mar;153(3):474-480.e1
9028111 - Nippon Ganka Gakkai Zasshi. 1997 Jan;101(1):74-82
22331974 - Clin Ophthalmol. 2012;6:175-9
3590481 - Trans Am Ophthalmol Soc. 1986;84:799-845
4196284 - Am J Ophthalmol. 1973 May;75(5):810-21
19830441 - Graefes Arch Clin Exp Ophthalmol. 2010 Mar;248(3):339-51
16411109 - Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):1045-51
19041477 - Ophthalmology. 2008 Dec;115(12):2229-34
6712911 - Br J Ophthalmol. 1984 May;68(5):329-31
19065564 - Lasers Surg Med. 2008 Dec;40(10 ):671-5
2847159 - Proc Natl Acad Sci U S A. 1988 Nov;85(22):8415-9
20644214 - Br J Ophthalmol. 2011 Apr;95(4):514-7
23345962 - Clin Ophthalmol. 2013;7:87-92
22684104 - J Clin Invest. 2012 Jul;122(7):2672-9
19898183 - Retina. 2009 Nov-Dec;29(10):1469-73
19427737 - Med Hypotheses. 2009 Sep;73(3):435-7
11453866 - Acta Ophthalmol Scand. 2001 Aug;79(4):417-21
20010322 - Retina. 2010 Jan;30(1):100-6
17891021 - Retina. 2007 Sep;27(7):943-6
8789858 - Retina. 1996;16(3):203-13
4042815 - Doc Ophthalmol. 1985 Aug 15;60(1):37-44
16303970 - Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4717-21
9003341 - Ophthalmology. 1996 Dec;103(12):2070-9; discussion 2079-80
6682293 - Am J Ophthalmol. 1983 Apr;95(4):457-66
14660450 - Br J Ophthalmol. 2003 Dec;87(12 ):1453-8
11131417 - Retina. 2000;20(6):633-7
15389356 - Swiss Med Wkly. 2004 Jul 10;134(27-28):395-8
1650792 - J Clin Invest. 1991 Aug;88(2):385-9
3061449 - Br J Ophthalmol. 1988 Nov;72(11):829-34
20714368 - Clin Ophthalmol. 2010 Aug 09;4:899-903
20472289 - Ophthalmology. 2010 Sep;117(9):1792-9
25372213 - Retin Cases Brief Rep. 2014 Winter;8(1):70-2
21389741 - Ophthalmic Res. 2011;46(3):160-3
20172070 - Am J Ophthalmol. 2010 Mar;149(3):441-6.e1-2
25390732 - Retin Cases Brief Rep. 2012 Winter;6(1):129-32
23758338 - Semin Ophthalmol. 2014 Mar;29(2):73-6
23519277 - Eye (Lond). 2013 May;27(5):612-20
18988165 - Eur J Ophthalmol. 2008 Nov-Dec;18(6):934-40
24268858 - Ophthalmology. 2014 Feb;121(2):558-65
15288381 - Med Hypotheses. 2004;63(3):524-7
22248651 - Arch Soc Esp Oftalmol. 2012 Jan;87(1):3-8
16732205 - Eye (Lond). 2008 Jan;22(1):100-6
10482095 - Am J Ophthalmol. 1999 Jul;128(1):63-8
19878226 - Clin Exp Ophthalmol. 2009 Nov;37(8):801-5
18046220 - Retina. 2007 Nov-Dec;27(9):1168-73
3209082 - Graefes Arch Clin Exp Ophthalmol. 1988;226(6):548-52
574397 - Br J Ophthalmol. 1979 Oct;63(10):674-7
21478806 - Retina. 2011 Oct;31(9):1937-43
20679080 - Br J Ophthalmol. 2011 Apr;95(4):518-23
10606450 - Retina. 1999;19(6):508-12
7926882 - Graefes Arch Clin Exp Ophthalmol. 1994 Aug;232(8):473-6
21448811 - Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1159-66
19485297 - Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):300-3
23549516 - Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Mar;159(1):120-3
8363466 - Arch Ophthalmol. 1993 Sep;111(9):1229-33
18523796 - Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1235-9
19958296 - Acta Ophthalmol. 2010 May;88(3):371-6
18538401 - Ophthalmology. 2008 Oct;115(10 ):1756-65
20616688 - Retina. 2010 Jul-Aug;30(7):1128-34
8318481 - Br J Ophthalmol. 1993 Jun;77(6):349-53
4621147 - Arch Ophthalmol. 1974 Apr;91(4):247-50
21140161 - Graefes Arch Clin Exp Ophthalmol. 2011 Jul;249(7):969-74
21427570 - Curr Opin Ophthalmol. 2011 May;22(3):166-73
23288136 - Eye (Lond). 2013 Mar;27(3):387-91
21052035 - Retina. 2011 Apr;31(4):759-65
8510413 - Klin Monbl Augenheilkd. 1993 Mar;202(3):199-205
21279982 - Eur J Ophthalmol. 2011 Jul-Aug;21(4):503-5
21742303 - Am J Ophthalmol. 2011 Nov;152(5):784-92.e2
19089442 - Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):597-607
24043941 - Ther Clin Risk Manag. 2013;9:355-60
21468346 - Clin Ophthalmol. 2011;5:355-60
17459318 - Am J Ophthalmol. 2007 Jun;143(6):977-983
23719402 - Retina. 2013 Nov-Dec;33(10):2096-102
7488581 - Br J Ophthalmol. 1995 Oct;79(10):922-5
20526231 - Retina. 2010 Oct;30(9):1465-71
24476668 - Ther Clin Risk Manag. 2014 Jan 09;10:37-43
3710187 - Graefes Arch Clin Exp Ophthalmol. 1986;224(4):321-4
14345766 - Trans Am Acad Ophthalmol Otolaryngol. 1965 Jul-Aug;69:605-13
3423431 - Retina. 1987 Fall;7(3):162-9
12208723 - Ophthalmology. 2002 Sep;109(9):1723-5
22915299 - Jpn J Ophthalmol. 2012 Nov;56(6):608-12
24696654 - ScientificWorldJournal. 2014 Feb 16;2014:631687
16033348 - Clin Exp Ophthalmol. 2005 Aug;33(4):369-72
5815620 - Nihon Ganka Kiyo. 1969 Mar;20(3):291-4
19896635 - Am J Ophthalmol. 2010 Feb;149(2):307-315.e2
22222922 - Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):803-8
21273946 - Retina. 2011 Apr;31(4):766-71
3749625 - Retina. 1986 Spring-Summer;6(2):81-4
24510173 - Ophthalmologe. 2014 Feb;111(2):173-80
24417755 - Clin Exp Optom. 2014 May;97(3):264-9
19184311 - Jpn J Ophthalmol. 2009 Jan;53(1):52-6
19421764 - Graefes Arch Clin Exp Ophthalmol. 2009 Oct;247(10 ):1315-23
23389551 - Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1697-705
19551677 - Eur J Ophthalmol. 2009 Jul-Aug;19(4):613-7
1122102 - Ann Ophthalmol. 1975 Feb;7(2):237-45
12359592 - Ophthalmology. 2002 Oct;109(10):1765-6
23841829 - Cutan Ocul Toxicol. 2014 Jun;33(2):115-9
16049541 - Can J Ophthalmol. 2005 Apr;40(2):217-21
22333850 - Can J Ophthalmol. 2012 Feb;47(1):42-4
23456099 - Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1909-17
16597666 - Br J Ophthalmol. 2006 Jul;90(7):869-74
22573069 - Eye (Lond). 2012 May;26(5):640-9
21810026 - J Ocul Pharmacol Ther. 2011 Dec;27(6):611-4
12049594 - Arch Ophthalmol. 2002 Jun;120(6):835-44
22718154 - Retina. 2012 Nov-Dec;32(10):2096-101
22053102 - Br J Ophthalmol. 2012 Jan;96(1):10-3
6477246 - Arch Ophthalmol. 1984 Sep;102(9):1299-302
21245962 - Mol Vis. 2011 Jan 11;17:99-103
23740451 - Eur Rev Med Pharmacol Sci. 2013 May;17(10):1369-73
Seong (10.1016/j.sjopt.2015.01.007_b0475) 2009; 223
Hadcock (10.1016/j.sjopt.2015.01.007_b0170) 1988; 85
Ficker (10.1016/j.sjopt.2015.01.007_b0270) 1988; 72
Okushiba (10.1016/j.sjopt.2015.01.007_b0130) 1997; 101
Lee (10.1016/j.sjopt.2015.01.007_b0525) 2011; 27
Ie (10.1016/j.sjopt.2015.01.007_b0095) 1993; 77
Lim (10.1016/j.sjopt.2015.01.007_b0395) 2011; 95
Shin (10.1016/j.sjopt.2015.01.007_b0490) 2011; 31
Giusti (10.1016/j.sjopt.2015.01.007_b0640) 2004; 63
Slusher (10.1016/j.sjopt.2015.01.007_b0250) 1986; 6
Copete (10.1016/j.sjopt.2015.01.007_b0365) 2012; 250
Imamura (10.1016/j.sjopt.2015.01.007_b0125) 2009; 29
Sakaue (10.1016/j.sjopt.2015.01.007_b0165) 1991; 88
Ravage (10.1016/j.sjopt.2015.01.007_b0590) 2012; 6
Harada (10.1016/j.sjopt.2015.01.007_b0055) 1985; 60
Von Graefe (10.1016/j.sjopt.2015.01.007_b0005) 1866; 12
Nicolò (10.1016/j.sjopt.2015.01.007_b0435) 2012; 153
Jung (10.1016/j.sjopt.2015.01.007_b0495) 2014; 97
Bujarborua (10.1016/j.sjopt.2015.01.007_b0205) 2001; 79
Folk (10.1016/j.sjopt.2015.01.007_b0210) 1984; 102
Tsakonas (10.1016/j.sjopt.2015.01.007_b0355) 2012; 6
Polak (10.1016/j.sjopt.2015.01.007_b0045) 1995; 79
Breukink (10.1016/j.sjopt.2015.01.007_b0575) 2014
Jampol (10.1016/j.sjopt.2015.01.007_b0160) 2002; 109
Fok (10.1016/j.sjopt.2015.01.007_b0275) 2011; 46
Chrapek (10.1016/j.sjopt.2015.01.007_b0615) 2013
Türkcü (10.1016/j.sjopt.2015.01.007_b0070) 2014; 33
Maumenee (10.1016/j.sjopt.2015.01.007_b0015) 1965; 69
Moon (10.1016/j.sjopt.2015.01.007_b0350) 2009; 247
Yannuzzi (10.1016/j.sjopt.2015.01.007_b0010) 1984; 91
Maruko (10.1016/j.sjopt.2015.01.007_b0090) 2011; 31
Maier (10.1016/j.sjopt.2015.01.007_b0570) 2014; 111
Aggio (10.1016/j.sjopt.2015.01.007_b0195) 2010; 30
Tittl (10.1016/j.sjopt.2015.01.007_b0135) 2005; 46
Chen (10.1016/j.sjopt.2015.01.007_b0280) 2008; 115
Lim (10.1016/j.sjopt.2015.01.007_b0535) 2011; 249
Schmidt-Erfurth (10.1016/j.sjopt.2015.01.007_b0330) 2002; 120
Yannuzzi (10.1016/j.sjopt.2015.01.007_b0025) 1986; 84
Avci (10.1016/j.sjopt.2015.01.007_b0610) 1993; 202
Wakakura (10.1016/j.sjopt.2015.01.007_b0050) 1984; 68
O’Connor (10.1016/j.sjopt.2015.01.007_b0105) 1975; 7
Baran (10.1016/j.sjopt.2015.01.007_b0200) 2005; 33
Gupta (10.1016/j.sjopt.2015.01.007_b0290) 2009; 37
Gass (10.1016/j.sjopt.2015.01.007_b0020) 1977; 83
Klein (10.1016/j.sjopt.2015.01.007_b0185) 1974; 91
Desai (10.1016/j.sjopt.2015.01.007_b0085) 2003; 95
Steinle (10.1016/j.sjopt.2015.01.007_b0585) 2012; 96
Iida (10.1016/j.sjopt.2015.01.007_b0120) 1999; 19
Hussain (10.1016/j.sjopt.2015.01.007_b0315) 2006; 244
Gruszka (10.1016/j.sjopt.2015.01.007_b0580) 2013; 17
Agarwal (10.1016/j.sjopt.2015.01.007_b0080) 2011
10.1016/j.sjopt.2015.01.007_b0540
Levy (10.1016/j.sjopt.2015.01.007_b0225) 2005; 40
Torres-Soriano (10.1016/j.sjopt.2015.01.007_b0530) 2008; 246
Lee (10.1016/j.sjopt.2015.01.007_b0455) 2011; 95
Lim (10.1016/j.sjopt.2015.01.007_b0505) 2010; 30
Leaver (10.1016/j.sjopt.2015.01.007_b0265) 1979; 63
Ross (10.1016/j.sjopt.2015.01.007_b0180) 2011; 22
Bae (10.1016/j.sjopt.2015.01.007_b0500) 2014; 121
Aydin (10.1016/j.sjopt.2015.01.007_b0515) 2013; 29
Chan (10.1016/j.sjopt.2015.01.007_b0340) 2003; 87
Maruko (10.1016/j.sjopt.2015.01.007_b0405) 2010; 117
Ohkuma (10.1016/j.sjopt.2015.01.007_b0460) 2013; 251
Kim (10.1016/j.sjopt.2015.01.007_b0400) 2014; 157
Bae (10.1016/j.sjopt.2015.01.007_b0450) 2011; 152
Dang (10.1016/j.sjopt.2015.01.007_b0650) 2013; 9
Inoue (10.1016/j.sjopt.2015.01.007_b0345) 2010; 149
Caccavale (10.1016/j.sjopt.2015.01.007_b0630) 2010; 4
Koskela (10.1016/j.sjopt.2015.01.007_b0215) 1994; 232
Semeraro (10.1016/j.sjopt.2015.01.007_b0520) 2012; 56
Shukla (10.1016/j.sjopt.2015.01.007_b0310) 2008; 22
Lai (10.1016/j.sjopt.2015.01.007_b0385) 2006; 90
Ratanasukon (10.1016/j.sjopt.2015.01.007_b0410) 2013; 7
Pikkel (10.1016/j.sjopt.2015.01.007_b0620) 2002; 109
10.1016/j.sjopt.2015.01.007_b0155
Giusti (10.1016/j.sjopt.2015.01.007_b0635) 2004; 134
Marmor (10.1016/j.sjopt.2015.01.007_b0150) 1988; 226
Negi (10.1016/j.sjopt.2015.01.007_b0145) 1984; 102
Yannuzzi (10.1016/j.sjopt.2015.01.007_b0240) 2010; 149
Arevalo (10.1016/j.sjopt.2015.01.007_b0510) 2011; 249
Chan (10.1016/j.sjopt.2015.01.007_b0545) 2007; 143
Forooghian (10.1016/j.sjopt.2015.01.007_b0600) 2011; 31
Ricci (10.1016/j.sjopt.2015.01.007_b0295) 2009; 247
Tatham (10.1016/j.sjopt.2015.01.007_b0605) 2006; 22
Rahbani-Nobar (10.1016/j.sjopt.2015.01.007_b0645) 2011; 17
Mudvari (10.1016/j.sjopt.2015.01.007_b0190) 2007; 27
Lanzetta (10.1016/j.sjopt.2015.01.007_b0285) 2008; 18
Gass (10.1016/j.sjopt.2015.01.007_b0100) 1973; 75
Bujarborua (10.1016/j.sjopt.2015.01.007_b0110) 2010; 248
Uetani (10.1016/j.sjopt.2015.01.007_b0430) 2012; 26
Tarantola (10.1016/j.sjopt.2015.01.007_b0335) 2008; 40
Chan (10.1016/j.sjopt.2015.01.007_b0325) 2008; 115
Schaal (10.1016/j.sjopt.2015.01.007_b0480) 2009; 19
Spitznas (10.1016/j.sjopt.2015.01.007_b0140) 1986; 224
Zhao (10.1016/j.sjopt.2015.01.007_b0425) 2009; 29
Spaide (10.1016/j.sjopt.2015.01.007_b0115) 1996; 16
Conrad (10.1016/j.sjopt.2015.01.007_b0230) 2014; 2014
Dang (10.1016/j.sjopt.2015.01.007_b0420) 2014; 10
Zhao (10.1016/j.sjopt.2015.01.007_b0175) 2012; 122
Maaranen (10.1016/j.sjopt.2015.01.007_b0220) 2000; 20
Lee (10.1016/j.sjopt.2015.01.007_b0375) 2009; 53
Kurup (10.1016/j.sjopt.2015.01.007_b0655) 2012; 32
Nicoló (10.1016/j.sjopt.2015.01.007_b0470) 2014; 157
Prünte (10.1016/j.sjopt.2015.01.007_b0040) 1996; 121
Nielsen (10.1016/j.sjopt.2015.01.007_b0560) 2011; 31
Meyerle (10.1016/j.sjopt.2015.01.007_b0550) 2007; 27
Giudice (10.1016/j.sjopt.2015.01.007_b0320) 2011; 5
Novak (10.1016/j.sjopt.2015.01.007_b0255) 1987; 7
Ruiz-Moreno (10.1016/j.sjopt.2015.01.007_b0360) 2010; 88
Robertson (10.1016/j.sjopt.2015.01.007_b0260) 1983; 95
Butler (10.1016/j.sjopt.2015.01.007_b0445) 2012; 47
Verma (10.1016/j.sjopt.2015.01.007_b0300) 2004; 4
Nelson (10.1016/j.sjopt.2015.01.007_b0595) 2014; 8
Mitsui (10.1016/j.sjopt.2015.01.007_b0245) 1969; 20
Spaide (10.1016/j.sjopt.2015.01.007_b0075) 1996; 103
Kawamura (10.1016/j.sjopt.2015.01.007_b0305) 2012; 6
Vasconcelos (10.1016/j.sjopt.2015.01.007_b0370) 2013; 251
Tittl (10.1016/j.sjopt.2015.01.007_b0065) 1999; 128
Sahin (10.1016/j.sjopt.2015.01.007_b0235) 2014; 29
Kang (10.1016/j.sjopt.2015.01.007_b0465) 2013; 27
Reibaldi (10.1016/j.sjopt.2015.01.007_b0380) 2010; 149
Bouzas (10.1016/j.sjopt.2015.01.007_b0060) 1993; 111
Karakus (10.1016/j.sjopt.2015.01.007_b0415) 2013; 27
Kim (10.1016/j.sjopt.2015.01.007_b0390) 2009; 40
Golshahi (10.1016/j.sjopt.2015.01.007_b0555) 2010; 88
Alcubierre (10.1016/j.sjopt.2015.01.007_b0440) 2012; 87
Lim (10.1016/j.sjopt.2015.01.007_b0485) 2010; 30
Yannuzzi (10.1016/j.sjopt.2015.01.007_b0035) 1987; 7
Caccavale (10.1016/j.sjopt.2015.01.007_b0625) 2009; 73
Gilbert (10.1016/j.sjopt.2015.01.007_b0030) 1984; 68
Bousquet (10.1016/j.sjopt.2015.01.007_b0565) 2013; 33
References_xml – volume: 77
  start-page: 349
  year: 1993
  end-page: 353
  ident: b0095
  article-title: Subretinal exudative deposits in central serous chorioretinopathy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Daily
– volume: 31
  start-page: 1937
  year: 2011
  end-page: 1943
  ident: b0490
  article-title: Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Lim
– volume: 68
  start-page: 329
  year: 1984
  end-page: 331
  ident: b0050
  article-title: Central serous chorioretinopathy complicating systemic corticosteroid treatment
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Ishikawa
– volume: 2014
  start-page: 631687
  year: 2014
  ident: b0230
  article-title: Temperament and character personality profile and illness-related stress in central serous chorioretinopathy
  publication-title: Sci World J
  contributor:
    fullname: Karpawitz-Godt
– volume: 40
  start-page: 671
  year: 2008
  end-page: 675
  ident: b0335
  article-title: Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy
  publication-title: Lasers Surg Med
  contributor:
    fullname: Agarwal
– volume: 149
  start-page: 361
  year: 2010
  end-page: 363
  ident: b0240
  article-title: Central serous chorioretinopathy: a personal perspective
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Yannuzzi
– volume: 122
  start-page: 2672
  year: 2012
  end-page: 2679
  ident: b0175
  article-title: Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
  publication-title: J Clin Investig
  contributor:
    fullname: Bousquet
– volume: 250
  start-page: 803
  year: 2012
  end-page: 808
  ident: b0365
  article-title: Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Montero
– volume: 22
  start-page: 145
  year: 2006
  end-page: 149
  ident: b0605
  article-title: The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT
  publication-title: J Ocul Pharmacol Ther
  contributor:
    fullname: Macfarlane
– volume: 115
  start-page: 2229
  year: 2008
  end-page: 2234
  ident: b0280
  article-title: Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage
  publication-title: Ophthalmology
  contributor:
    fullname: Lin
– volume: 117
  start-page: 1792
  year: 2010
  end-page: 1799
  ident: b0405
  article-title: Subfoveal choroidal thickness after treatment of central serous chorioretinopathy
  publication-title: Ophthalmology
  contributor:
    fullname: Spaide
– volume: 72
  start-page: 829
  year: 1988
  end-page: 834
  ident: b0270
  article-title: Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Leaver
– volume: 83
  start-page: 456
  year: 1977
  end-page: 467
  ident: b0020
  article-title: Photocoagulation treatment of idiopathic central serous choroidopathy
  publication-title: Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol
  contributor:
    fullname: Gass
– volume: 95
  start-page: 518
  year: 2011
  end-page: 523
  ident: b0455
  article-title: Photodynamic therapy for steroid-associated central serous chorioretinopathy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Kim
– year: 2014
  ident: b0575
  article-title: The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy
  publication-title: Acta Ophthalmol
  contributor:
    fullname: Hoyng
– volume: 30
  start-page: 100
  year: 2010
  end-page: 106
  ident: b0505
  article-title: Intravitreal bevacizumab injection for central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Kwon
– volume: 88
  start-page: 576
  year: 2010
  end-page: 581
  ident: b0555
  article-title: Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study
  publication-title: Acta Ophthalmol
  contributor:
    fullname: Eter
– volume: 68
  start-page: 815
  year: 1984
  end-page: 820
  ident: b0030
  article-title: Long-term follow-up of central serous chorioretinopathy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Fine
– volume: 90
  start-page: 869
  year: 2006
  end-page: 874
  ident: b0385
  article-title: Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Lam
– volume: 6
  start-page: 1639
  year: 2012
  end-page: 1644
  ident: b0355
  article-title: Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Ladas
– start-page: 3
  year: 2013
  end-page: 6
  ident: b0615
  article-title: Treatment of central serous chorioretinopathy with beta-blocker metipranolol
  publication-title: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
  contributor:
    fullname: Sin
– volume: 40
  start-page: 300
  year: 2009
  end-page: 303
  ident: b0390
  article-title: Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy
  publication-title: Ophthalmic Surg Lasers Imag
  contributor:
    fullname: Huh
– volume: 19
  start-page: 613
  year: 2009
  end-page: 617
  ident: b0480
  article-title: Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy
  publication-title: Eur J Ophthalmol
  contributor:
    fullname: Dithmar
– volume: 121
  start-page: 26
  year: 1996
  end-page: 34
  ident: b0040
  article-title: Choroidal capillary and venous congestion in central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Flammer
– volume: 102
  start-page: 1299
  year: 1984
  end-page: 1302
  ident: b0210
  article-title: Visual function abnormalities in central serous retinopathy
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Brown
– volume: 20
  start-page: 633
  year: 2000
  end-page: 637
  ident: b0220
  article-title: Color vision defects after central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Mäntyjärvi
– volume: 32
  start-page: 2096
  year: 2012
  end-page: 2101
  ident: b0655
  article-title: Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis
  publication-title: Retina
  contributor:
    fullname: Callanan
– volume: 9
  start-page: 355
  year: 2013
  end-page: 360
  ident: b0650
  article-title: The effect of eradicating
  publication-title: Ther Clin Risk Manage
  contributor:
    fullname: Zhu
– volume: 46
  start-page: 160
  year: 2011
  end-page: 163
  ident: b0275
  article-title: Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy
  publication-title: Ophthalmic Res
  contributor:
    fullname: Lai
– volume: 224
  start-page: 321
  year: 1986
  end-page: 324
  ident: b0140
  article-title: Pathogenesis of central serous retinopathy: a new working hypothesis
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Spitznas
– year: 2011
  ident: b0080
  article-title: Gass’ atlas of macular diseases
  contributor:
    fullname: Agarwal
– volume: 248
  start-page: 339
  year: 2010
  end-page: 351
  ident: b0110
  article-title: Smokestack leak in central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Deka
– volume: 85
  start-page: 8415
  year: 1988
  end-page: 8419
  ident: b0170
  article-title: Regulation of beta-adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Malbon
– volume: 29
  start-page: 73
  year: 2014
  end-page: 76
  ident: b0235
  article-title: Psychological distress and poor quality of life in patients with central serous chorioretinopathy
  publication-title: Semin Ophthalmol
  contributor:
    fullname: Yüksel
– volume: 95
  start-page: 457
  year: 1983
  end-page: 466
  ident: b0260
  article-title: Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Ilstrup
– volume: 27
  start-page: 943
  year: 2007
  end-page: 946
  ident: b0550
  article-title: Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Yannuzzi
– volume: 30
  start-page: 1465
  year: 2010
  end-page: 1471
  ident: b0485
  article-title: Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Shin
– volume: 17
  start-page: 1369
  year: 2013
  end-page: 1373
  ident: b0580
  article-title: Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Gruszka
– volume: 33
  start-page: 115
  year: 2014
  end-page: 119
  ident: b0070
  article-title: Effects of smoking on visual acuity of central serous chorioretinopathy patients
  publication-title: Cutan Ocul Toxicol
  contributor:
    fullname: Sahin
– volume: 37
  start-page: 801
  year: 2009
  end-page: 805
  ident: b0290
  article-title: Micropulse diode laser photocoagulation for central serous chorio-retinopathy
  publication-title: Clin Experiment Ophthalmol
  contributor:
    fullname: Sivaprasad
– volume: 149
  start-page: 441-6.e1-2
  year: 2010
  ident: b0345
  article-title: Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Gomi
– volume: 5
  start-page: 355
  year: 2011
  end-page: 360
  ident: b0320
  article-title: Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Galan
– volume: 4
  start-page: 15
  year: 2004
  ident: b0300
  article-title: Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]
  publication-title: BMC Ophthalmol
  contributor:
    fullname: Tewari
– volume: 27
  start-page: 611
  year: 2011
  end-page: 614
  ident: b0525
  article-title: The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumab
  publication-title: J Ocul Pharmacol Ther
  contributor:
    fullname: Adelman
– volume: 6
  start-page: 175
  year: 2012
  end-page: 179
  ident: b0305
  article-title: Transpupillary thermotherapy for atypical central serous chorioretinopathy
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Hori
– volume: 30
  start-page: 1128
  year: 2010
  end-page: 1134
  ident: b0195
  article-title: Clinical factors related to visual outcome in central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Farah
– volume: 4
  start-page: 899
  year: 2010
  end-page: 903
  ident: b0630
  article-title: Low-dose aspirin as treatment for central serous chorioretinopathy
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Ferentini
– volume: 46
  start-page: 4717
  year: 2005
  end-page: 4721
  ident: b0135
  article-title: Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy
  publication-title: Invest Ophthalmol Vis Sci
  contributor:
    fullname: Schmetterer
– volume: 149
  start-page: 307-315.e2
  year: 2010
  ident: b0380
  article-title: Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Longo
– volume: 79
  start-page: 922
  year: 1995
  end-page: 925
  ident: b0045
  article-title: Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Snyers
– volume: 152
  start-page: 784-92.e2
  year: 2011
  ident: b0450
  article-title: A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Kim
– volume: 31
  start-page: 1928
  year: 2011
  end-page: 1936
  ident: b0560
  article-title: Oral mifepristone for chronic central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Jampol
– volume: 84
  start-page: 799
  year: 1986
  end-page: 845
  ident: b0025
  article-title: Type A behavior and central serous chorioretinopathy
  publication-title: Trans Am Ophthalmol Soc
  contributor:
    fullname: Yannuzzi
– volume: 7
  start-page: 162
  year: 1987
  end-page: 169
  ident: b0255
  article-title: Krypton and argon laser photocoagulation for central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Rice
– volume: 7
  start-page: 237
  year: 1975
  end-page: 245
  ident: b0105
  article-title: Multifocal serous choroidopathy
  publication-title: Ann Ophthalmol
  contributor:
    fullname: O’Connor
– volume: 88
  start-page: 371
  year: 2010
  end-page: 376
  ident: b0360
  article-title: Photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Acta Ophthalmol
  contributor:
    fullname: Armadá
– volume: 232
  start-page: 473
  year: 1994
  end-page: 476
  ident: b0215
  article-title: Contrast sensitivity after resolution of central serous retinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: von Dickhoff
– volume: 6
  start-page: 81
  year: 1986
  end-page: 84
  ident: b0250
  article-title: Krypton red laser photocoagulation in selected cases of central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Slusher
– volume: 251
  start-page: 1697
  year: 2013
  end-page: 1705
  ident: b0370
  article-title: Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Santos
– volume: 7
  start-page: 111
  year: 1987
  end-page: 131
  ident: b0035
  article-title: Type-A behavior and central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Yannuzzi
– volume: 249
  start-page: 1159
  year: 2011
  end-page: 1166
  ident: b0510
  article-title: Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Espinoza
– volume: 69
  start-page: 605
  year: 1965
  end-page: 613
  ident: b0015
  article-title: Macular diseases: clinical manifestations
  publication-title: Trans Am Acad Ophthalmol Otolaryngol
  contributor:
    fullname: Maumenee
– volume: 223
  start-page: 343
  year: 2009
  end-page: 347
  ident: b0475
  article-title: Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect
  publication-title: Ophthalmologica
  contributor:
    fullname: Kim
– volume: 8
  start-page: 70
  year: 2014
  end-page: 72
  ident: b0595
  article-title: Rifampin induced hepatotoxicity during treatment for chronic central serous chorioretinopathy
  publication-title: Retin Cases Br Rep
  contributor:
    fullname: Nielsen
– volume: 202
  start-page: 199
  year: 1993
  end-page: 205
  ident: b0610
  article-title: Treatment of central serous choroidopathy with the beta receptor blocker metoprolol (preliminary results)
  publication-title: Klin Monbl Augenheilkd
  contributor:
    fullname: Deutman
– volume: 75
  start-page: 810
  year: 1973
  end-page: 821
  ident: b0100
  article-title: Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Gass
– volume: 115
  start-page: 1756
  year: 2008
  end-page: 1765
  ident: b0325
  article-title: Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial
  publication-title: Ophthalmology
  contributor:
    fullname: Lam
– volume: 60
  start-page: 37
  year: 1985
  end-page: 44
  ident: b0055
  article-title: Six cases of central serous choroidopathy induced by systemic corticosteroid therapy
  publication-title: Doc Ophthalmol
  contributor:
    fullname: Harada
– volume: 16
  start-page: 203
  year: 1996
  end-page: 213
  ident: b0115
  article-title: Indocyanine green videoangiography of older patients with central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Haas
– volume: 27
  start-page: 612
  year: 2013
  end-page: 620
  ident: b0415
  article-title: Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes
  publication-title: Eye (Lond)
  contributor:
    fullname: Demirok
– volume: 111
  start-page: 1229
  year: 1993
  end-page: 1233
  ident: b0060
  article-title: Central serous chorioretinopathy in endogenous hypercortisolism
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Kaiser-Kupfer
– volume: 56
  start-page: 608
  year: 2012
  end-page: 612
  ident: b0520
  article-title: Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
  publication-title: Jpn J Ophthalmol
  contributor:
    fullname: Costagliola
– volume: 249
  start-page: 969
  year: 2011
  end-page: 974
  ident: b0535
  article-title: The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Kim
– volume: 31
  start-page: 766
  year: 2011
  end-page: 771
  ident: b0600
  article-title: Finasteride for chronic central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Meyerle
– volume: 153
  start-page: 474-480.e1
  year: 2012
  ident: b0435
  article-title: Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Traverso
– volume: 109
  start-page: 1723
  year: 2002
  end-page: 1725
  ident: b0620
  article-title: Acetazolamide for central serous retinopathy
  publication-title: Ophthalmology
  contributor:
    fullname: Miller
– volume: 109
  start-page: 1765
  year: 2002
  end-page: 1766
  ident: b0160
  article-title: Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies
  publication-title: Ophthalmology
  contributor:
    fullname: Yannuzzi
– volume: 29
  start-page: 1155
  year: 2009
  end-page: 1161
  ident: b0425
  article-title: Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin
  publication-title: Retina
  contributor:
    fullname: Xiao
– volume: 22
  start-page: 166
  year: 2011
  end-page: 173
  ident: b0180
  article-title: Review and update of central serous chorioretinopathy
  publication-title: Curr Opin Ophthalmol
  contributor:
    fullname: Mohamed
– volume: 95
  start-page: 553
  year: 2003
  end-page: 559
  ident: b0085
  article-title: Central serous chorioretinopathy in African Americans
  publication-title: J Natl Med Assoc
  contributor:
    fullname: Jacobsen
– volume: 87
  start-page: 3
  year: 2012
  end-page: 8
  ident: b0440
  article-title: Low-fluence photodynamic therapy in chronic central serous chorioretinopathy
  publication-title: Arch la Soc Española Oftalmol
  contributor:
    fullname: Rubio
– volume: 79
  start-page: 417
  year: 2001
  end-page: 421
  ident: b0205
  article-title: Long-term follow-up of idiopathic central serous chorioretinopathy without laser
  publication-title: Acta Ophthalmol Scand
  contributor:
    fullname: Bujarborua
– volume: 97
  start-page: 264
  year: 2014
  end-page: 269
  ident: b0495
  article-title: Cytokine levels of the aqueous humour in central serous chorioretinopathy
  publication-title: Clin Exp Optom
  contributor:
    fullname: Yang
– volume: 20
  start-page: 291
  year: 1969
  end-page: 294
  ident: b0245
  article-title: Xenon light-exposure as a treatment of central serous retinopathy (a preliminary report)
  publication-title: Nihon Ganka Kiyo
  contributor:
    fullname: Kanagawa
– volume: 63
  start-page: 524
  year: 2004
  end-page: 527
  ident: b0640
  article-title: Association of
  publication-title: Med Hypotheses
  contributor:
    fullname: Giusti
– volume: 102
  start-page: 445
  year: 1984
  end-page: 449
  ident: b0145
  article-title: Experimental serous retinal detachment and focal pigment epithelial damage
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Marmor
– volume: 17
  start-page: 99
  year: 2011
  end-page: 103
  ident: b0645
  article-title: The effect of
  publication-title: Mol Vis
  contributor:
    fullname: Ghorbanihaghjo
– volume: 47
  start-page: 42
  year: 2012
  end-page: 44
  ident: b0445
  article-title: Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Can J Ophthalmol
  contributor:
    fullname: Forooghian
– volume: 22
  start-page: 100
  year: 2008
  end-page: 106
  ident: b0310
  article-title: Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy
  publication-title: Eye (Lond)
  contributor:
    fullname: Kim
– volume: 18
  start-page: 934
  year: 2008
  end-page: 940
  ident: b0285
  article-title: Nonvisible subthreshold micropulse diode laser (810
  publication-title: Eur J Ophthalmol
  contributor:
    fullname: Bandello
– volume: 73
  start-page: 435
  year: 2009
  end-page: 437
  ident: b0625
  article-title: A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy
  publication-title: Med Hypotheses
  contributor:
    fullname: Ferentini
– volume: 247
  start-page: 597
  year: 2009
  end-page: 607
  ident: b0295
  article-title: Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Dorin
– volume: 26
  start-page: 640
  year: 2012
  end-page: 649
  ident: b0430
  article-title: Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Eye (Lond)
  contributor:
    fullname: Terasaki
– volume: 29
  start-page: 10
  year: 2013
  end-page: 13
  ident: b0515
  article-title: The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy
  publication-title: J Ocul Pharmacol Ther
  contributor:
    fullname: Aydin
– volume: 101
  start-page: 74
  year: 1997
  end-page: 82
  ident: b0130
  article-title: Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography
  publication-title: Nihon Ganka Gakkai Zasshi
  contributor:
    fullname: Takeda
– volume: 143
  start-page: 977
  year: 2007
  end-page: 983
  ident: b0545
  article-title: Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Lam
– volume: 134
  start-page: 395
  year: 2004
  end-page: 398
  ident: b0635
  article-title: and idiopathic central serous chorioretinopathy
  publication-title: Swiss Med Wkly
  contributor:
    fullname: Mauget-Faÿsse
– volume: 63
  start-page: 674
  year: 1979
  end-page: 677
  ident: b0265
  article-title: Argon laser photocoagulation in the treatment of central serous retinopathy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Williams
– volume: 244
  start-page: 1045
  year: 2006
  end-page: 1051
  ident: b0315
  article-title: Transpupillary thermotherapy for chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Das
– volume: 91
  start-page: 1554
  year: 1984
  end-page: 1572
  ident: b0010
  article-title: Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy
  publication-title: Ophthalmology
  contributor:
    fullname: Altomonte
– volume: 27
  start-page: 387
  year: 2013
  end-page: 391
  ident: b0465
  article-title: Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy
  publication-title: Eye (Lond)
  contributor:
    fullname: Kim
– volume: 128
  start-page: 63
  year: 1999
  end-page: 68
  ident: b0065
  article-title: Systemic findings associated with central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Wong
– volume: 53
  start-page: 52
  year: 2009
  end-page: 56
  ident: b0375
  article-title: Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy
  publication-title: Jpn J Ophthalmol
  contributor:
    fullname: Lee
– volume: 40
  start-page: 217
  year: 2005
  end-page: 221
  ident: b0225
  article-title: Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy
  publication-title: Can J Ophthalmol
  contributor:
    fullname: Lifshitz
– volume: 31
  start-page: 759
  year: 2011
  end-page: 765
  ident: b0090
  article-title: Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Sekiryu
– volume: 29
  start-page: 1469
  year: 2009
  end-page: 1473
  ident: b0125
  article-title: Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Spaide
– volume: 103
  start-page: 2070
  year: 1996
  end-page: 2079
  ident: b0075
  article-title: Central serous chorioretinopathy in younger and older adults
  publication-title: Ophthalmology
  contributor:
    fullname: Haas
– volume: 95
  start-page: 514
  year: 2011
  end-page: 517
  ident: b0395
  article-title: Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Lee
– volume: 33
  start-page: 2096
  year: 2013
  end-page: 2102
  ident: b0565
  article-title: Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study
  publication-title: Retina
  contributor:
    fullname: Behar-Cohen
– volume: 111
  start-page: 173
  year: 2014
  end-page: 180
  ident: b0570
  article-title: Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy
  publication-title: Ophthalmologe
  contributor:
    fullname: Lohmann
– volume: 120
  start-page: 835
  year: 2002
  end-page: 844
  ident: b0330
  article-title: Histopathological changes following photodynamic therapy in human eyes
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Naumann
– volume: 12
  start-page: 211
  year: 1866
  end-page: 215
  ident: b0005
  article-title: Ueber central recidivierende retinitis
  publication-title: Graefe’s Arch Clin Exp Ophthalmol
  contributor:
    fullname: Von Graefe
– volume: 19
  start-page: 508
  year: 1999
  end-page: 512
  ident: b0120
  article-title: Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Shimizu
– volume: 91
  start-page: 247
  year: 1974
  end-page: 250
  ident: b0185
  article-title: Experience with nontreatment of central serous choroidopathy
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Chandra
– volume: 251
  start-page: 1909
  year: 2013
  end-page: 1917
  ident: b0460
  article-title: One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Tsuneoka
– volume: 247
  start-page: 1315
  year: 2009
  end-page: 1323
  ident: b0350
  article-title: Prognostic factors related to photodynamic therapy for central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Chung
– volume: 226
  start-page: 548
  year: 1988
  end-page: 552
  ident: b0150
  article-title: New hypotheses on the pathogenesis and treatment of serous retinal detachment
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Marmor
– volume: 157
  start-page: 366-373.e1
  year: 2014
  ident: b0400
  article-title: Half-dose photodynamic therapy targeting the leakage point on the fluorescein angiography in acute central serous chorioretinopathy: a pilot study
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Lee
– volume: 157
  start-page: 1033
  year: 2014
  end-page: 1037
  ident: b0470
  article-title: Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  contributor:
    fullname: Alovisi
– volume: 246
  start-page: 1235
  year: 2008
  end-page: 1239
  ident: b0530
  article-title: A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports)
  publication-title: Graefes Arch Clin Exp Ophthalmol
  contributor:
    fullname: Kon-Jara
– volume: 96
  start-page: 10
  year: 2012
  end-page: 13
  ident: b0585
  article-title: Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Singh
– volume: 88
  start-page: 385
  year: 1991
  end-page: 389
  ident: b0165
  article-title: Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells
  publication-title: J Clin Invest
  contributor:
    fullname: Hoffman
– volume: 6
  start-page: 129
  year: 2012
  end-page: 132
  ident: b0590
  article-title: Chronic central serous chorioretinopathy responsive to rifampin
  publication-title: Retin Cases Br Rep
  contributor:
    fullname: Merrill
– volume: 33
  start-page: 369
  year: 2005
  end-page: 372
  ident: b0200
  article-title: Long-term macular function in eyes with central serous chorioretinopathy
  publication-title: Clin Experiment Ophthalmol
  contributor:
    fullname: Esgin
– volume: 10
  start-page: 37
  year: 2014
  end-page: 43
  ident: b0420
  article-title: Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy
  publication-title: Ther Clin Risk Manage
  contributor:
    fullname: Xu
– volume: 27
  start-page: 1168
  year: 2007
  end-page: 1173
  ident: b0190
  article-title: The natural history of pigment epithelial detachment associated with central serous chorioretinopathy
  publication-title: Retina
  contributor:
    fullname: Fu
– volume: 87
  start-page: 1453
  year: 2003
  end-page: 1459
  ident: b0340
  article-title: Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
  publication-title: Br J Ophthalmol
  contributor:
    fullname: Chan
– volume: 7
  start-page: 87
  year: 2013
  end-page: 92
  ident: b0410
  article-title: Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Jirarattanasopa
– volume: 121
  start-page: 558
  year: 2014
  end-page: 565
  ident: b0500
  article-title: Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial
  publication-title: Ophthalmology
  contributor:
    fullname: Kim
– volume: 121
  start-page: 558
  issue: 2
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0500
  article-title: Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2013.09.024
  contributor:
    fullname: Bae
– volume: 20
  start-page: 291
  issue: 3
  year: 1969
  ident: 10.1016/j.sjopt.2015.01.007_b0245
  article-title: Xenon light-exposure as a treatment of central serous retinopathy (a preliminary report)
  publication-title: Nihon Ganka Kiyo
  contributor:
    fullname: Mitsui
– volume: 63
  start-page: 674
  issue: 10
  year: 1979
  ident: 10.1016/j.sjopt.2015.01.007_b0265
  article-title: Argon laser photocoagulation in the treatment of central serous retinopathy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.63.10.674
  contributor:
    fullname: Leaver
– start-page: 3
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0615
  article-title: Treatment of central serous chorioretinopathy with beta-blocker metipranolol
  publication-title: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
  contributor:
    fullname: Chrapek
– volume: 122
  start-page: 2672
  issue: 7
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0175
  article-title: Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
  publication-title: J Clin Investig
  doi: 10.1172/JCI61427
  contributor:
    fullname: Zhao
– volume: 32
  start-page: 2096
  issue: 10
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0655
  article-title: Low-dose methotrexate for the treatment of chronic central serous chorioretinopathy: a retrospective analysis
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31825dd281
  contributor:
    fullname: Kurup
– volume: 83
  start-page: 456
  issue: 3 Pt 1
  year: 1977
  ident: 10.1016/j.sjopt.2015.01.007_b0020
  article-title: Photocoagulation treatment of idiopathic central serous choroidopathy
  publication-title: Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol
  contributor:
    fullname: Gass
– volume: 103
  start-page: 2070
  issue: 12
  year: 1996
  ident: 10.1016/j.sjopt.2015.01.007_b0075
  article-title: Central serous chorioretinopathy in younger and older adults
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(96)30386-2
  contributor:
    fullname: Spaide
– volume: 109
  start-page: 1723
  issue: 9
  year: 2002
  ident: 10.1016/j.sjopt.2015.01.007_b0620
  article-title: Acetazolamide for central serous retinopathy
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(02)01157-0
  contributor:
    fullname: Pikkel
– volume: 12
  start-page: 211
  year: 1866
  ident: 10.1016/j.sjopt.2015.01.007_b0005
  article-title: Ueber central recidivierende retinitis
  publication-title: Graefe’s Arch Clin Exp Ophthalmol
  contributor:
    fullname: Von Graefe
– volume: 73
  start-page: 435
  issue: 3
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0625
  article-title: A new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathy
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2009.03.036
  contributor:
    fullname: Caccavale
– volume: 87
  start-page: 3
  issue: 1
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0440
  article-title: Low-fluence photodynamic therapy in chronic central serous chorioretinopathy
  publication-title: Arch la Soc Española Oftalmol
  doi: 10.1016/j.oftal.2011.06.012
  contributor:
    fullname: Alcubierre
– volume: 91
  start-page: 1554
  issue: 12
  year: 1984
  ident: 10.1016/j.sjopt.2015.01.007_b0010
  article-title: Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(84)34117-3
  contributor:
    fullname: Yannuzzi
– volume: 157
  start-page: 1033
  issue: 5
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0470
  article-title: Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2014.01.022
  contributor:
    fullname: Nicoló
– volume: 84
  start-page: 799
  year: 1986
  ident: 10.1016/j.sjopt.2015.01.007_b0025
  article-title: Type A behavior and central serous chorioretinopathy
  publication-title: Trans Am Ophthalmol Soc
  contributor:
    fullname: Yannuzzi
– volume: 16
  start-page: 203
  issue: 3
  year: 1996
  ident: 10.1016/j.sjopt.2015.01.007_b0115
  article-title: Indocyanine green videoangiography of older patients with central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/00006982-199616030-00004
  contributor:
    fullname: Spaide
– volume: 31
  start-page: 1928
  issue: 9
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0560
  article-title: Oral mifepristone for chronic central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31821c3ef6
  contributor:
    fullname: Nielsen
– volume: 2014
  start-page: 631687
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0230
  article-title: Temperament and character personality profile and illness-related stress in central serous chorioretinopathy
  publication-title: Sci World J
  doi: 10.1155/2014/631687
  contributor:
    fullname: Conrad
– volume: 46
  start-page: 160
  issue: 3
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0275
  article-title: Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy
  publication-title: Ophthalmic Res
  doi: 10.1159/000324599
  contributor:
    fullname: Fok
– volume: 95
  start-page: 518
  issue: 4
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0455
  article-title: Photodynamic therapy for steroid-associated central serous chorioretinopathy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2010.181149
  contributor:
    fullname: Lee
– volume: 79
  start-page: 417
  issue: 4
  year: 2001
  ident: 10.1016/j.sjopt.2015.01.007_b0205
  article-title: Long-term follow-up of idiopathic central serous chorioretinopathy without laser
  publication-title: Acta Ophthalmol Scand
  doi: 10.1034/j.1600-0420.2001.079004417.x
  contributor:
    fullname: Bujarborua
– volume: 27
  start-page: 611
  issue: 6
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0525
  article-title: The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumab
  publication-title: J Ocul Pharmacol Ther
  doi: 10.1089/jop.2011.0045
  contributor:
    fullname: Lee
– volume: 226
  start-page: 548
  issue: 6
  year: 1988
  ident: 10.1016/j.sjopt.2015.01.007_b0150
  article-title: New hypotheses on the pathogenesis and treatment of serous retinal detachment
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF02169203
  contributor:
    fullname: Marmor
– volume: 33
  start-page: 2096
  issue: 10
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0565
  article-title: Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study
  publication-title: Retina
  doi: 10.1097/IAE.0b013e318297a07a
  contributor:
    fullname: Bousquet
– volume: 115
  start-page: 1756
  issue: 10
  year: 2008
  ident: 10.1016/j.sjopt.2015.01.007_b0325
  article-title: Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2008.04.014
  contributor:
    fullname: Chan
– year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0080
  contributor:
    fullname: Agarwal
– volume: 31
  start-page: 766
  issue: 4
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0600
  article-title: Finasteride for chronic central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181f04a35
  contributor:
    fullname: Forooghian
– volume: 79
  start-page: 922
  issue: 10
  year: 1995
  ident: 10.1016/j.sjopt.2015.01.007_b0045
  article-title: Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.79.10.922
  contributor:
    fullname: Polak
– volume: 247
  start-page: 1315
  issue: 10
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0350
  article-title: Prognostic factors related to photodynamic therapy for central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-009-1104-8
  contributor:
    fullname: Moon
– volume: 7
  start-page: 87
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0410
  article-title: Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
  publication-title: Clin Ophthalmol
  doi: 10.2147/OPTH.S39584
  contributor:
    fullname: Ratanasukon
– volume: 69
  start-page: 605
  year: 1965
  ident: 10.1016/j.sjopt.2015.01.007_b0015
  article-title: Macular diseases: clinical manifestations
  publication-title: Trans Am Acad Ophthalmol Otolaryngol
  contributor:
    fullname: Maumenee
– volume: 95
  start-page: 553
  issue: 7
  year: 2003
  ident: 10.1016/j.sjopt.2015.01.007_b0085
  article-title: Central serous chorioretinopathy in African Americans
  publication-title: J Natl Med Assoc
  contributor:
    fullname: Desai
– volume: 22
  start-page: 100
  issue: 1
  year: 2008
  ident: 10.1016/j.sjopt.2015.01.007_b0310
  article-title: Transpupillary thermotherapy for subfoveal leaks in central serous chorioretinopathy
  publication-title: Eye (Lond)
  doi: 10.1038/sj.eye.6702449
  contributor:
    fullname: Shukla
– volume: 224
  start-page: 321
  issue: 4
  year: 1986
  ident: 10.1016/j.sjopt.2015.01.007_b0140
  article-title: Pathogenesis of central serous retinopathy: a new working hypothesis
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF02150023
  contributor:
    fullname: Spitznas
– volume: 17
  start-page: 99
  issue: January
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0645
  article-title: The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy
  publication-title: Mol Vis
  contributor:
    fullname: Rahbani-Nobar
– volume: 27
  start-page: 612
  issue: 5
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0415
  article-title: Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes
  publication-title: Eye (Lond)
  doi: 10.1038/eye.2013.24
  contributor:
    fullname: Karakus
– volume: 40
  start-page: 671
  issue: 10
  year: 2008
  ident: 10.1016/j.sjopt.2015.01.007_b0335
  article-title: Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy
  publication-title: Lasers Surg Med
  doi: 10.1002/lsm.20720
  contributor:
    fullname: Tarantola
– volume: 96
  start-page: 10
  issue: 1
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0585
  article-title: Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2011-300183
  contributor:
    fullname: Steinle
– volume: 153
  start-page: 474-480.e1
  issue: 3
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0435
  article-title: Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.08.015
  contributor:
    fullname: Nicolò
– volume: 8
  start-page: 70
  issue: 1
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0595
  article-title: Rifampin induced hepatotoxicity during treatment for chronic central serous chorioretinopathy
  publication-title: Retin Cases Br Rep
  doi: 10.1097/ICB.0000000000000007
  contributor:
    fullname: Nelson
– volume: 27
  start-page: 1168
  issue: 9
  year: 2007
  ident: 10.1016/j.sjopt.2015.01.007_b0190
  article-title: The natural history of pigment epithelial detachment associated with central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e318156db8a
  contributor:
    fullname: Mudvari
– volume: 102
  start-page: 1299
  issue: 9
  year: 1984
  ident: 10.1016/j.sjopt.2015.01.007_b0210
  article-title: Visual function abnormalities in central serous retinopathy
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1984.01040031049021
  contributor:
    fullname: Folk
– volume: 31
  start-page: 759
  issue: 4
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0090
  article-title: Subretinal dot-like precipitates and yellow material in central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181fbce8e
  contributor:
    fullname: Maruko
– volume: 19
  start-page: 508
  issue: 6
  year: 1999
  ident: 10.1016/j.sjopt.2015.01.007_b0120
  article-title: Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/00006982-199911000-00005
  contributor:
    fullname: Iida
– volume: 29
  start-page: 1155
  issue: 8
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0425
  article-title: Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dose of verteporfin
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181a6c028
  contributor:
    fullname: Zhao
– volume: 56
  start-page: 608
  issue: 6
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0520
  article-title: Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
  publication-title: Jpn J Ophthalmol
  doi: 10.1007/s10384-012-0162-3
  contributor:
    fullname: Semeraro
– volume: 249
  start-page: 969
  issue: 7
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0535
  article-title: The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-010-1581-9
  contributor:
    fullname: Lim
– volume: 115
  start-page: 2229
  issue: 12
  year: 2008
  ident: 10.1016/j.sjopt.2015.01.007_b0280
  article-title: Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2008.08.026
  contributor:
    fullname: Chen
– volume: 68
  start-page: 329
  issue: 5
  year: 1984
  ident: 10.1016/j.sjopt.2015.01.007_b0050
  article-title: Central serous chorioretinopathy complicating systemic corticosteroid treatment
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.68.5.329
  contributor:
    fullname: Wakakura
– volume: 90
  start-page: 869
  issue: 7
  year: 2006
  ident: 10.1016/j.sjopt.2015.01.007_b0385
  article-title: Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2006.090282
  contributor:
    fullname: Lai
– volume: 53
  start-page: 52
  issue: 1
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0375
  article-title: Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy
  publication-title: Jpn J Ophthalmol
  doi: 10.1007/s10384-008-0613-z
  contributor:
    fullname: Lee
– volume: 249
  start-page: 1159
  issue: 8
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0510
  article-title: Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-011-1651-7
  contributor:
    fullname: Arevalo
– volume: 202
  start-page: 199
  issue: 3
  year: 1993
  ident: 10.1016/j.sjopt.2015.01.007_b0610
  article-title: Treatment of central serous choroidopathy with the beta receptor blocker metoprolol (preliminary results)
  publication-title: Klin Monbl Augenheilkd
  doi: 10.1055/s-2008-1045583
  contributor:
    fullname: Avci
– volume: 109
  start-page: 1765
  issue: 10
  year: 2002
  ident: 10.1016/j.sjopt.2015.01.007_b0160
  article-title: Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies
  publication-title: Ophthalmology
  doi: 10.1016/S0161-6420(02)01303-9
  contributor:
    fullname: Jampol
– volume: 120
  start-page: 835
  issue: 6
  year: 2002
  ident: 10.1016/j.sjopt.2015.01.007_b0330
  article-title: Histopathological changes following photodynamic therapy in human eyes
  publication-title: Arch Ophthalmol
  contributor:
    fullname: Schmidt-Erfurth
– volume: 246
  start-page: 1235
  issue: 9
  year: 2008
  ident: 10.1016/j.sjopt.2015.01.007_b0530
  article-title: A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports)
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-008-0856-x
  contributor:
    fullname: Torres-Soriano
– volume: 33
  start-page: 115
  issue: 2
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0070
  article-title: Effects of smoking on visual acuity of central serous chorioretinopathy patients
  publication-title: Cutan Ocul Toxicol
  doi: 10.3109/15569527.2013.810633
  contributor:
    fullname: Türkcü
– volume: 30
  start-page: 1128
  issue: 7
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0195
  article-title: Clinical factors related to visual outcome in central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181cdf381
  contributor:
    fullname: Aggio
– volume: 223
  start-page: 343
  issue: 5
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0475
  article-title: Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect
  publication-title: Ophthalmologica
  doi: 10.1159/000224782
  contributor:
    fullname: Seong
– volume: 75
  start-page: 810
  issue: 5
  year: 1973
  ident: 10.1016/j.sjopt.2015.01.007_b0100
  article-title: Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/0002-9394(73)90887-8
  contributor:
    fullname: Gass
– volume: 250
  start-page: 803
  issue: 6
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0365
  article-title: Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-011-1900-9
  contributor:
    fullname: Copete
– volume: 149
  start-page: 307-315.e2
  issue: 2
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0380
  article-title: Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2009.08.026
  contributor:
    fullname: Reibaldi
– volume: 9
  start-page: 355
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0650
  article-title: The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients
  publication-title: Ther Clin Risk Manage
  doi: 10.2147/TCRM.S50407
  contributor:
    fullname: Dang
– volume: 244
  start-page: 1045
  issue: 8
  year: 2006
  ident: 10.1016/j.sjopt.2015.01.007_b0315
  article-title: Transpupillary thermotherapy for chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-005-0175-4
  contributor:
    fullname: Hussain
– volume: 40
  start-page: 217
  issue: 2
  year: 2005
  ident: 10.1016/j.sjopt.2015.01.007_b0225
  article-title: Central serous chorioretinopathy in patients receiving systemic corticosteroid therapy
  publication-title: Can J Ophthalmol
  doi: 10.1016/S0008-4182(05)80040-7
  contributor:
    fullname: Levy
– volume: 26
  start-page: 640
  issue: 5
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0430
  article-title: Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Eye (Lond)
  doi: 10.1038/eye.2012.66
  contributor:
    fullname: Uetani
– volume: 19
  start-page: 613
  issue: 4
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0480
  article-title: Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy
  publication-title: Eur J Ophthalmol
  doi: 10.1177/112067210901900415
  contributor:
    fullname: Schaal
– volume: 37
  start-page: 801
  issue: 8
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0290
  article-title: Micropulse diode laser photocoagulation for central serous chorio-retinopathy
  publication-title: Clin Experiment Ophthalmol
  doi: 10.1111/j.1442-9071.2009.02157.x
  contributor:
    fullname: Gupta
– volume: 18
  start-page: 934
  issue: 6
  year: 2008
  ident: 10.1016/j.sjopt.2015.01.007_b0285
  article-title: Nonvisible subthreshold micropulse diode laser (810nm) treatment of central serous chorioretinopathy. A pilot study
  publication-title: Eur J Ophthalmol
  doi: 10.1177/112067210801800613
  contributor:
    fullname: Lanzetta
– volume: 40
  start-page: 300
  issue: 3
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0390
  article-title: Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy
  publication-title: Ophthalmic Surg Lasers Imag
  doi: 10.3928/15428877-20090430-14
  contributor:
    fullname: Kim
– volume: 87
  start-page: 1453
  year: 2003
  ident: 10.1016/j.sjopt.2015.01.007_b0340
  article-title: Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.87.12.1453
  contributor:
    fullname: Chan
– volume: 22
  start-page: 145
  issue: 2
  year: 2006
  ident: 10.1016/j.sjopt.2015.01.007_b0605
  article-title: The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT
  publication-title: J Ocul Pharmacol Ther
  doi: 10.1089/jop.2006.22.145
  contributor:
    fullname: Tatham
– volume: 101
  start-page: 74
  issue: 1
  year: 1997
  ident: 10.1016/j.sjopt.2015.01.007_b0130
  article-title: Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography
  publication-title: Nihon Ganka Gakkai Zasshi
  contributor:
    fullname: Okushiba
– ident: 10.1016/j.sjopt.2015.01.007_b0540
  doi: 10.5301/EJO.2011.6290
– volume: 60
  start-page: 37
  issue: 1
  year: 1985
  ident: 10.1016/j.sjopt.2015.01.007_b0055
  article-title: Six cases of central serous choroidopathy induced by systemic corticosteroid therapy
  publication-title: Doc Ophthalmol
  doi: 10.1007/BF00164568
  contributor:
    fullname: Harada
– volume: 77
  start-page: 349
  issue: 6
  year: 1993
  ident: 10.1016/j.sjopt.2015.01.007_b0095
  article-title: Subretinal exudative deposits in central serous chorioretinopathy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.77.6.349
  contributor:
    fullname: Ie
– volume: 97
  start-page: 264
  issue: 3
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0495
  article-title: Cytokine levels of the aqueous humour in central serous chorioretinopathy
  publication-title: Clin Exp Optom
  doi: 10.1111/cxo.12125
  contributor:
    fullname: Jung
– volume: 7
  start-page: 111
  issue: 2
  year: 1987
  ident: 10.1016/j.sjopt.2015.01.007_b0035
  article-title: Type-A behavior and central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/00006982-198700720-00009
  contributor:
    fullname: Yannuzzi
– volume: 6
  start-page: 81
  issue: 2
  year: 1986
  ident: 10.1016/j.sjopt.2015.01.007_b0250
  article-title: Krypton red laser photocoagulation in selected cases of central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/00006982-198600620-00003
  contributor:
    fullname: Slusher
– volume: 95
  start-page: 514
  issue: 4
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0395
  article-title: Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2010.182121
  contributor:
    fullname: Lim
– volume: 31
  start-page: 1937
  issue: 9
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0490
  article-title: Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e31820a6a17
  contributor:
    fullname: Shin
– volume: 111
  start-page: 173
  issue: 2
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0570
  article-title: Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy
  publication-title: Ophthalmologe
  doi: 10.1007/s00347-013-3001-0
  contributor:
    fullname: Maier
– volume: 95
  start-page: 457
  issue: 4
  year: 1983
  ident: 10.1016/j.sjopt.2015.01.007_b0260
  article-title: Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/0002-9394(83)90265-9
  contributor:
    fullname: Robertson
– volume: 17
  start-page: 1369
  issue: 10
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0580
  article-title: Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report
  publication-title: Eur Rev Med Pharmacol Sci
  contributor:
    fullname: Gruszka
– volume: 91
  start-page: 247
  issue: 4
  year: 1974
  ident: 10.1016/j.sjopt.2015.01.007_b0185
  article-title: Experience with nontreatment of central serous choroidopathy
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1974.03900060257001
  contributor:
    fullname: Klein
– volume: 46
  start-page: 4717
  issue: 12
  year: 2005
  ident: 10.1016/j.sjopt.2015.01.007_b0135
  article-title: Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.05-0268
  contributor:
    fullname: Tittl
– volume: 128
  start-page: 63
  issue: 1
  year: 1999
  ident: 10.1016/j.sjopt.2015.01.007_b0065
  article-title: Systemic findings associated with central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)00075-6
  contributor:
    fullname: Tittl
– volume: 10
  start-page: 37
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0420
  article-title: Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy
  publication-title: Ther Clin Risk Manage
  doi: 10.2147/TCRM.S54213
  contributor:
    fullname: Dang
– volume: 4
  start-page: 15
  year: 2004
  ident: 10.1016/j.sjopt.2015.01.007_b0300
  article-title: Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484]
  publication-title: BMC Ophthalmol
  doi: 10.1186/1471-2415-4-15
  contributor:
    fullname: Verma
– volume: 111
  start-page: 1229
  issue: 9
  year: 1993
  ident: 10.1016/j.sjopt.2015.01.007_b0060
  article-title: Central serous chorioretinopathy in endogenous hypercortisolism
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1993.01090090081024
  contributor:
    fullname: Bouzas
– volume: 143
  start-page: 977
  issue: 6
  year: 2007
  ident: 10.1016/j.sjopt.2015.01.007_b0545
  article-title: Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2007.02.039
  contributor:
    fullname: Chan
– ident: 10.1016/j.sjopt.2015.01.007_b0155
– volume: 232
  start-page: 473
  issue: 8
  year: 1994
  ident: 10.1016/j.sjopt.2015.01.007_b0215
  article-title: Contrast sensitivity after resolution of central serous retinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/BF00195356
  contributor:
    fullname: Koskela
– volume: 4
  start-page: 899
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0630
  article-title: Low-dose aspirin as treatment for central serous chorioretinopathy
  publication-title: Clin Ophthalmol
  doi: 10.2147/OPTH.S12583
  contributor:
    fullname: Caccavale
– volume: 29
  start-page: 73
  issue: 2
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0235
  article-title: Psychological distress and poor quality of life in patients with central serous chorioretinopathy
  publication-title: Semin Ophthalmol
  doi: 10.3109/08820538.2013.793728
  contributor:
    fullname: Sahin
– volume: 29
  start-page: 10
  issue: 1
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0515
  article-title: The efficacy of intravitreal bevacizumab for acute central serous chorioretinopathy
  publication-title: J Ocul Pharmacol Ther
  doi: 10.1089/jop.2012.0072
  contributor:
    fullname: Aydin
– volume: 121
  start-page: 26
  issue: 1
  year: 1996
  ident: 10.1016/j.sjopt.2015.01.007_b0040
  article-title: Choroidal capillary and venous congestion in central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(14)70531-8
  contributor:
    fullname: Prünte
– volume: 7
  start-page: 162
  issue: 3
  year: 1987
  ident: 10.1016/j.sjopt.2015.01.007_b0255
  article-title: Krypton and argon laser photocoagulation for central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/00006982-198700730-00005
  contributor:
    fullname: Novak
– volume: 20
  start-page: 633
  issue: 6
  year: 2000
  ident: 10.1016/j.sjopt.2015.01.007_b0220
  article-title: Color vision defects after central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/00006982-200011000-00008
  contributor:
    fullname: Maaranen
– volume: 30
  start-page: 1465
  issue: 9
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0485
  article-title: Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181d8e7fe
  contributor:
    fullname: Lim
– volume: 85
  start-page: 8415
  issue: 22
  year: 1988
  ident: 10.1016/j.sjopt.2015.01.007_b0170
  article-title: Regulation of beta-adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.85.22.8415
  contributor:
    fullname: Hadcock
– volume: 88
  start-page: 371
  issue: 3
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0360
  article-title: Photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2008.01408.x
  contributor:
    fullname: Ruiz-Moreno
– volume: 63
  start-page: 524
  issue: 3
  year: 2004
  ident: 10.1016/j.sjopt.2015.01.007_b0640
  article-title: Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis
  publication-title: Med Hypotheses
  doi: 10.1016/j.mehy.2004.02.020
  contributor:
    fullname: Giusti
– volume: 5
  start-page: 355
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0320
  article-title: Large-spot subthreshold transpupillary thermotherapy for chronic serous macular detachment
  publication-title: Clin Ophthalmol
  doi: 10.2147/OPTH.S16014
  contributor:
    fullname: Giudice
– volume: 248
  start-page: 339
  issue: 3
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0110
  article-title: Smokestack leak in central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-009-1212-5
  contributor:
    fullname: Bujarborua
– volume: 6
  start-page: 175
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0305
  article-title: Transpupillary thermotherapy for atypical central serous chorioretinopathy
  publication-title: Clin Ophthalmol
  doi: 10.2147/OPTH.S28239
  contributor:
    fullname: Kawamura
– volume: 6
  start-page: 1639
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0355
  article-title: Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
  publication-title: Clin Ophthalmol
  contributor:
    fullname: Tsakonas
– volume: 68
  start-page: 815
  issue: 11
  year: 1984
  ident: 10.1016/j.sjopt.2015.01.007_b0030
  article-title: Long-term follow-up of central serous chorioretinopathy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.68.11.815
  contributor:
    fullname: Gilbert
– volume: 33
  start-page: 369
  issue: 4
  year: 2005
  ident: 10.1016/j.sjopt.2015.01.007_b0200
  article-title: Long-term macular function in eyes with central serous chorioretinopathy
  publication-title: Clin Experiment Ophthalmol
  doi: 10.1111/j.1442-9071.2005.01027.x
  contributor:
    fullname: Baran
– volume: 102
  start-page: 445
  issue: 3
  year: 1984
  ident: 10.1016/j.sjopt.2015.01.007_b0145
  article-title: Experimental serous retinal detachment and focal pigment epithelial damage
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.1984.01040030359038
  contributor:
    fullname: Negi
– volume: 247
  start-page: 597
  issue: 5
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0295
  article-title: Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-008-1014-1
  contributor:
    fullname: Ricci
– volume: 47
  start-page: 42
  issue: 1
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0445
  article-title: Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Can J Ophthalmol
  doi: 10.1016/j.jcjo.2011.12.020
  contributor:
    fullname: Butler
– volume: 7
  start-page: 237
  issue: 2
  year: 1975
  ident: 10.1016/j.sjopt.2015.01.007_b0105
  article-title: Multifocal serous choroidopathy
  publication-title: Ann Ophthalmol
  contributor:
    fullname: O’Connor
– volume: 29
  start-page: 1469
  issue: 10
  year: 2009
  ident: 10.1016/j.sjopt.2015.01.007_b0125
  article-title: Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181be0a83
  contributor:
    fullname: Imamura
– volume: 22
  start-page: 166
  issue: 3
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0180
  article-title: Review and update of central serous chorioretinopathy
  publication-title: Curr Opin Ophthalmol
  doi: 10.1097/ICU.0b013e3283459826
  contributor:
    fullname: Ross
– volume: 149
  start-page: 441-6.e1-2
  issue: 3
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0345
  article-title: Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2009.10.011
  contributor:
    fullname: Inoue
– volume: 72
  start-page: 829
  issue: 11
  year: 1988
  ident: 10.1016/j.sjopt.2015.01.007_b0270
  article-title: Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.72.11.829
  contributor:
    fullname: Ficker
– volume: 88
  start-page: 576
  issue: 5
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0555
  article-title: Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study
  publication-title: Acta Ophthalmol
  doi: 10.1111/j.1755-3768.2008.01467.x
  contributor:
    fullname: Golshahi
– year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0575
  article-title: The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.12392
  contributor:
    fullname: Breukink
– volume: 30
  start-page: 100
  issue: 1
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0505
  article-title: Intravitreal bevacizumab injection for central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e3181bcf0b4
  contributor:
    fullname: Lim
– volume: 6
  start-page: 129
  issue: 1
  year: 2012
  ident: 10.1016/j.sjopt.2015.01.007_b0590
  article-title: Chronic central serous chorioretinopathy responsive to rifampin
  publication-title: Retin Cases Br Rep
  doi: 10.1097/ICB.0b013e3182235561
  contributor:
    fullname: Ravage
– volume: 134
  start-page: 395
  issue: 27–28
  year: 2004
  ident: 10.1016/j.sjopt.2015.01.007_b0635
  article-title: Helicobacter pylori and idiopathic central serous chorioretinopathy
  publication-title: Swiss Med Wkly
  contributor:
    fullname: Giusti
– volume: 27
  start-page: 387
  issue: 3
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0465
  article-title: Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy
  publication-title: Eye (Lond)
  doi: 10.1038/eye.2012.273
  contributor:
    fullname: Kang
– volume: 152
  start-page: 784-92.e2
  issue: 5
  year: 2011
  ident: 10.1016/j.sjopt.2015.01.007_b0450
  article-title: A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2011.04.008
  contributor:
    fullname: Bae
– volume: 251
  start-page: 1697
  issue: 7
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0370
  article-title: Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-013-2270-2
  contributor:
    fullname: Vasconcelos
– volume: 149
  start-page: 361
  issue: 3
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0240
  article-title: Central serous chorioretinopathy: a personal perspective
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2009.11.017
  contributor:
    fullname: Yannuzzi
– volume: 88
  start-page: 385
  issue: 2
  year: 1991
  ident: 10.1016/j.sjopt.2015.01.007_b0165
  article-title: Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI115315
  contributor:
    fullname: Sakaue
– volume: 251
  start-page: 1909
  issue: 8
  year: 2013
  ident: 10.1016/j.sjopt.2015.01.007_b0460
  article-title: One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-013-2289-4
  contributor:
    fullname: Ohkuma
– volume: 157
  start-page: 366-373.e1
  issue: 2
  year: 2014
  ident: 10.1016/j.sjopt.2015.01.007_b0400
  article-title: Half-dose photodynamic therapy targeting the leakage point on the fluorescein angiography in acute central serous chorioretinopathy: a pilot study
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2013.10.013
  contributor:
    fullname: Kim
– volume: 117
  start-page: 1792
  issue: 9
  year: 2010
  ident: 10.1016/j.sjopt.2015.01.007_b0405
  article-title: Subfoveal choroidal thickness after treatment of central serous chorioretinopathy
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2010.01.023
  contributor:
    fullname: Maruko
– volume: 27
  start-page: 943
  issue: 7
  year: 2007
  ident: 10.1016/j.sjopt.2015.01.007_b0550
  article-title: Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy
  publication-title: Retina
  doi: 10.1097/IAE.0b013e318050ca69
  contributor:
    fullname: Meyerle
SSID ssj0068383
Score 2.1889458
SecondaryResourceType review_article
Snippet Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 278
SubjectTerms Central serous chorioretinopathy
Central serous retinopathy
Corticosteroids
CSCR
Photodynamic therapy
Review
Treatment
SummonAdditionalLinks – databaseName: ScienceDirect Open Access Journals (Elsevier)
  dbid: IXB
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8MwGA5jB_Eifju_iODRsrZLsuTgYQ7HEOZFB7uFpEmwHtqxj4P_3jdNO5yKB49t34bw5OXJG_LkCUK3XMEsZmkcaZq5iOg0i5RQOuIudUbDkiipJP-TZzaekqcZnbXQsDkL42WVNfcHTq_Yun7TrdHszvO8-5JA9hAKLEyDawvwcI8m1SG-2UPDxowHK04fHPnoxnmo0ngt38u5F1QmwbvT3yn7--z0s_r8LqL8MiuN9tFeXU7iQejxAWrZ4hDtTOoN8yN0Pwh7_EucFxhqPbwRluPS4bpRDGlYrpcYmHCRV8cai9LfVPxxjKajx9fhOKpvTIgyQsUq4ilRjsOiB4o-LrijsUqV1U4RlvWISpSzDAiNaKUyJkzGIYgqZUTCmWEZ652gdlEW9gxhZmKSQTvOsB4RXHPNUtVPFDfOmtTYDrprkJLzYIwhG8XYu6yAlR5YGScSgO0g1qApt8ZXAnX__eNNg72EzPfbGaqwAIqEtZTwZjJp3EGnYSw2PUmhsGKiLzqovzVKmwDvqr39pcjfKndtAitCqHvO_9vhC7Trn4Lg7xK1V4u1vYLCZaWvq8z8BEuW7rY
  priority: 102
  providerName: Elsevier
Title Advances in the treatment of central serous chorioretinopathy
URI https://dx.doi.org/10.1016/j.sjopt.2015.01.007
https://www.ncbi.nlm.nih.gov/pubmed/26586979
https://search.proquest.com/docview/1749601620
https://pubmed.ncbi.nlm.nih.gov/PMC4625218
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFH44HsSLuDtuRPBonbaTxvTgQUVxYURBYW4hK45oZ9Dx4L_3pWkGNzx46aVJCF8ebyHf-wKwyyVGMVukiSq0S6jKdSJLqRLucmcUlkRZTfnvXbPze3rZL_pTUMRemJq0r9Vgv3p63q8GDzW3cvSsO5En1rnpnVBM2jE0dVrQQgONJXpwv4wH7c3Md-fQokuj1FBN6np9HI48gzILYp2pf4MvxyDMSs_l-j0y_cw8vxMoP0Wks3mYa1JJchS2vABTtlqEmV5zWb4Eh0fhfv-VDCqCeR6ZkMrJ0JFmUYImiMU_QS_4MqhbGquhf6X4fRnuz07vTs6T5rWERNOiHCc8p9JxLHgw4eMld0Uqc2mVk5TpLpWZdJahM6NKSs1KozkOKqQ0ZcaZYZp1V2C6GlZ2DQgzKdW4jjOsS0uuuGK5PMgkN86a3Ng27EWkxCiIYojIFnsUNcbCYyzSTCDGbWARTdHE9RCvBbrtvyfuROwFWr2_ypCVRVAE1lGlF5LJ0zashrOY7CSeZxsOvpzSZIBX1P76Bw2tVtZuDGv93zM3YNbvP7D9NmF6_PJmtzBrGattaF30j_F7dcu3a4v9ALfm8FU
link.rule.ids 230,315,730,783,787,888,3513,27936,27937,45886,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9sgFH7KUmnbZVrXbst-lUo91ortYAKHHdKqUdIluTSVckNgQHMPdtSkh_33exg7ataqh10NRujj6eM98fEBcMYV7mI2iyOd5S6iOs0jJZSOuEud0VgSJbXkf75gk1t6vcpWHbhs78J4WWXD_YHTa7ZuvvQbNPvroujfJBg9NEMWzoJryys48NcufZhPVxctHTMevDh978h3b62HapHX5q5ae0VlEsw7_aOyz29PT9PPf1WUj7al8Xt41-STZBSmfAgdW36A1_PmxPwIfo7CIf-GFCXBZI_slOWkcqQZlGAcVg8bglR4X9T3GsvKP1X85xhux1fLy0nUPJkQ5TQT24inVDmOVQ9mfVxwl8UqVVY7RVk-oCpRzjJkNKqVypkwOcdOmVJGJJwZlrPBR-iWVWk_A2EmpjmO4wwbUME11yxVw0Rx46xJje3BeYuUXAdnDNlKxu5kDaz0wMo4kQhsD1iLptxbYInc_fKPpy32EkPfn2eo0iIoEosp4d1k0rgHn8Ja7GaSYmbFxFD0YLi3SrsO3lZ7v6Usftf22hRLQkx8vvzvhE_gzWQ5n8nZdPHrK7z1LUH99w262_sH-x2zmK3-UUfpX3f08eQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xSIgLYqesRuJIaJI6xjlwQEDFVsQBJG6WV1EESUXLgb9nHCcVmzhwjmM548m8Gfn5DcAel4hiNosjlWkXUZXqSOZSRdylzigsiZKK8t-7Yef39PIhe_jU6qsi7WvVPyieXw6K_mPFrRy86HbDE2vf9k4oJu0ITe2Bce1JmMZ_NmZNoR6CMONBgTPxd3Ro1qGN4FBF7Ro-lQPPo0yCZGfsO_GlCMUs94yu3_HpZ_75nUb5CZe68zBXJ5TkOCx8ASZssQgzvfrIfAmOjsMp_5D0C4LZHhlTy0npSD0pQUcs34YEY-Frv7rYWJS-V_H7Mtx3z-5OzqO6Z0KkaZaPIp5S6TiWPZj28Zy7LJaptMpJynSHykQ6yzCkUSWlZrnRHAdlUpo84cwwzTorMFWUhV0DwkxMNc7jDOvQnCuuWCoPE8mNsyY1tgX7jaXEIEhjiIYz9iQqGwtvYxEnAm3cAtZYU9ToHlBbYPD--8XdxvYCfd8faMjColEEVlO5l5NJ4xashr0Yr6TZzxYcftml8QCvq_31Cbpbpa9du9f6v9_cgZnb0664vri52oBZ_ymB_rcJU6PXN7uFacxIbVcO-wGtQ_LF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advances+in+the+treatment+of+central+serous+chorioretinopathy&rft.jtitle=Saudi+journal+of+ophthalmology&rft.au=Abouammoh%2C+Marwan+A&rft.date=2015-10-01&rft.issn=1319-4534&rft.volume=29&rft.issue=4&rft.spage=278&rft_id=info:doi/10.1016%2Fj.sjopt.2015.01.007&rft_id=info%3Apmid%2F26586979&rft.externalDocID=26586979
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1319-4534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1319-4534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1319-4534&client=summon